NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email TOKYO, May 9, 2025—Canon announced today that the company has been awarded the Platinum rating1 for the first time for its sustainability efforts by France-based global sustainability ratings organization EcoVadis.Read More